rss
J Med Genet 2007;44:670-672 doi:10.1136/jmg.2007.050971
  • Letters to JMG

The IRF5 polymorphism in type 1 diabetes

  1. Hui-Qi Qu,
  2. Luc Marchand,
  3. Rosemary Grabs,
  4. Constantin Polychronakos
  1. Endocrine Genetics Lab, The McGill University Health Center (Montreal Children’s Hospital), Montréal, Québec, Canada
  1. Correspondence to:
 Dr Constantin Polychronakos
 The McGill University Health Center (Montreal Children’s Hospital), 2300 Tupper, Montréal, Quebec H3H 1P3, Canada; constantin.polychronakos{at}mcgill.ca
  • Received 6 April 2007
  • Accepted 22 May 2007
  • Revised 18 May 2007
  • Published Online First 8 June 2007

Abstract

The interferon regulatory factor 5 gene (IRF5) has been shown to play a crucial role in harmful immune responses by induction of proinflammatory cytokines. Functional genetic variants associated with increasd IRF5 expression of specific isoforms are associated with systemic lupus erythematosus (SLE) and it is possible that they may also predispose to other autoimmune disorders. We tested the association of two IRF5 SNPs, correlated with IRF5 expression and SLE risk, in 947 nuclear family trios type 1 diabetes (T1D) using the transmission disequilibrium test. Our results suggest that the functional IRF5 variations do not confer an obvious risk for T1D.

Footnotes

  • Competing interests: None declared.

  • Published Online First 8 June 2007

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.